Human papillomavirus (HPV) infection and vaccines: Knowledge, attitude and perception among female students at the University of Lagos, Lagos, Nigeria

被引:74
作者
Christian Chigozie Makwe
Rose Ihuoma Anorlu
Kofoworola Abimbola Odeyemi
机构
[1] Department of Obstetrics and Gynaecology, College of Medicine, University of Lagos/Lagos University Teaching Hospital, Idi-Araba, Lagos
[2] Department of Community Health and Primary Health Care, College of Medicine, University of Lagos/Lagos University Teaching Hospital, Idi-Araba, Lagos
关键词
Female students; HPV vaccine; Human papillomavirus; Knowledge; Nigeria;
D O I
10.1016/j.jegh.2012.11.001
中图分类号
学科分类号
摘要
Aim: This study sought to determine knowledge of and attitude towards human papillomavirus (HPV) infection, HPV-related diseases and HPV vaccines among female undergraduate students at the University of Lagos. Methods: A self-administered questionnaire was administered between May and July 2010, to 368 female students aged 16-29. years, who were selected from two faculties of the University of Lagos using two-stage sampling method. Data collected included: socio-demographic characteristics, sexual history, awareness and knowledge of HPV infection, cervical cancer and genital warts, and HPV vaccine; the perceived risk of acquiring genital HPV infection and developing cervical cancer or genital warts, and the willingness to receive an HPV vaccine. Results: Only 64 (17.7%) and 52 (14.4%) of the students had ever heard of HPV infection and HPV vaccines respectively. The median HPV knowledge on a 15-item score was 2. Overall, only 11.1% knew that genital HPV infection can cause cervical cancer. Fourteen (6.9%) of those who were aware of cervical cancer agreed they were at risk of developing the disease. Of the 52 students who had heard of the HPV vaccine, 24 (46.2%) knew it was given for cervical cancer prevention and 30 (57.7%) expressed their willingness to receive the vaccine. Conclusion: The knowledge of and the perceived susceptibility to HPV infection and HPV-related diseases among female students in the University of Lagos were generally low. The need for a well-designed HPV-educational program to bridge the knowledge gap cannot be overemphasized. © 2012 Ministry of Health, Saudi Arabia.
引用
收藏
页码:199 / 206
页数:7
相关论文
共 27 条
[1]  
Baseman J.G., Koutsky L.A., The epidemiology of human papillomavirus infections, J Clin Virol, 32, SUPPL. 1, (2005)
[2]  
Keam S.J., Harper D.M., Human papillomavirus types 16 and 18 vaccine (recombinant, AS04 adjuvanted, adsorbed) [Cervarix], Drugs, 68, pp. 359-372, (2008)
[3]  
Munoz N., Manalastas R., Pitisuttithum P., Et al., Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial, Lancet, 373, pp. 1949-1957, (2009)
[4]  
Dunne E.F., Unger E.R., Sternberg M., Prevalence of HPV infection among females in the United States, JAMA, 297, pp. 813-819, (2007)
[5]  
Giuliano A.R., Tortolero-Luna G., Ferrer E., Et al., Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions, Vaccine, 26, SUPPL. 10, (2008)
[6]  
Burchell A.N., Winer R.L., de Sanjose S., Franco E.L., Epidemiology and transmission dynamics of genital HPV infection, Vaccine, 24, SUPPL. 3, (2006)
[7]  
Moscicki A., Schiffmanb M., Kjaer S., Villa L.L., Updating the natural history of HPV and anogenital cancer, Vaccine, 24, SUPPL. 3, (2006)
[8]  
Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008, Int J Cancer, 127, pp. 2893-2917, (2010)
[9]  
Clifford G., Franceschi S., Diaz M., Munoz N., Villa L.L., HPV type-distribution in women with and without cervical neoplastic diseases, Vaccine, 24, SUPPL. 3, (2006)
[10]  
Lacey C.J., Therapy for genital human papillomavirus-related disease, J Clin Virol, 32, SUPPL. 1, (2005)